1h Free Analyst Time
The biotechnology market in the US is forecasted to grow by USD 295.3 billion during 2024-2029, accelerating at a CAGR of 11.5% during the forecast period. The report on the biotechnology market in the US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of chronic and rare diseases, aging population and rising healthcare needs, and government support and funding.
The biotechnology market in the US is segmented as below:
By Product
- Biologics
- Therapeutics
- Diagnostics
- Industrial biotechnology
- Others
By Type
- Red biotechnology
- White biotechnology
- Green biotechnology
- Grey biotechnology
- Others
By Geographical Landscape
- North America
The report on the biotechnology market in the US covers the following areas:
- Biotechnology Market in the US sizing
- Biotechnology Market in the US forecast
- Biotechnology Market in the US industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Product
9 Market Segmentation by Type
10 Customer Landscape
11 Drivers, Challenges, and Opportunity/Restraints
12 Competitive Landscape
13 Competitive Analysis
14 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the biotechnology market in us: AbbVie Inc., Amgen Inc., Biogen Inc., BioMarin Pharmaceutical Inc., bluebird bio Inc., Eli Lilly and Co., Genentech Inc., Gilead Sciences Inc., Illumina Inc., Johnson and Johnson Inc., Moderna Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Sarepta Therapeutics Inc., Thermo Fisher Scientific Inc., and Vertex Pharmaceuticals Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is incorporation of artificial intelligence and machine learning."
According to the report, one of the major drivers for this market is the rising prevalence of chronic and rare diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- Biogen Inc.
- BioMarin Pharmaceutical Inc.
- bluebird bio Inc.
- Eli Lilly and Co.
- Genentech Inc.
- Gilead Sciences Inc.
- Illumina Inc.
- Johnson and Johnson Inc.
- Moderna Inc.
- Pfizer Inc.
- Regeneron Pharmaceuticals Inc.
- Sarepta Therapeutics Inc.
- Thermo Fisher Scientific Inc.
- Vertex Pharmaceuticals Inc.
